Clinical trials in Dordrecht – page 65

1 624 clinical trials in Dordrecht, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Dordrecht at a glance

1 624

clinical trials

Research sites1

Quick filters

1 624 trials in Dordrecht

Open in trial search

Immune-mediated myositis

Not yet recruiting

Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

Registered drugNo placebo

Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:Novartis Pharma AG

Contact Research Centre

Pancreatic carcinoma

Not yet recruiting

Study on the Effects of Rintatolimod After FOLFIRINOX in Patients with Locally Advanced Pancreatic Cancer

InvestigationalNo placebo

Study on the Effects of Rintatolimod After FOLFIRINOX in Patients with Locally Advanced Pancreatic Cancer

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Rintatolimod
Sponsor:Aim Immunotech Inc.

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Study on WT1-loaded CBDC Vaccine for Children and Young Adults with Acute Myeloid Leukemia

InvestigationalNo placebo

Study on WT1-loaded CBDC Vaccine for Children and Young Adults with Acute Myeloid Leukemia

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Autologous Cord Blood-Derived Dendritic Cells Loaded With Wt1 Peptide Pool
Sponsor:Princess Maxima Center For Pediatric Oncology

Contact Research Centre

Allogenic stem cell transplantation

Not yet recruiting

Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia

InvestigationalNo placebo

Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia

InvestigationalNo placebo

The Netherlands

Participants:18–64 years
Substances:Dorocubicel
Sponsor:Excellthera Inc.

Contact Research Centre

Colitis ulcerative

Not yet recruiting

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Adalimumab
Sponsor:Abbvie Deutschland GmbH & Co. KG

Contact Research Centre

Skin cancer+1

Not yet recruiting

Study of DYP688 for Patients with Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

InvestigationalNo placebo

Study of DYP688 for Patients with Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:DYP688
Sponsor:Novartis Pharma AG

Contact Research Centre

Heart disease congenital+1

Not yet recruiting

Study on Allopurinol Sodium for Brain Injury Prevention in Newborns with Critical Congenital Heart Disease Undergoing Heart Surgery

Registered drug

Study on Allopurinol Sodium for Brain Injury Prevention in Newborns with Critical Congenital Heart Disease Undergoing Heart Surgery

Registered drug

The Netherlands

Participants:0–17 years
Substances:Allopurinol Sodium
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Acute myeloid leukaemia+2

Not yet recruiting

Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

Registered drugNo placebo

Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Ellipses Pharma Limited

Contact Research Centre

COVID-19

Not yet recruiting

Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

Registered drugNo placebo

Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Colchicine
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Pancreatic carcinoma

Not yet recruiting

Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

Registered drugNo placebo

Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Neurofibromatosis

Not yet recruiting

Study on Trametinib for Patients with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibromas

Registered drugNo placebo

Study on Trametinib for Patients with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibromas

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Trametinib
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Coronary artery disease

Not yet recruiting

Study on Ticagrelor and Clopidogrel for Patients with Coronary Artery Disease Undergoing PCI

Registered drugNo placebo

Study on Ticagrelor and Clopidogrel for Patients with Coronary Artery Disease Undergoing PCI

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Clopidogrel
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Dordrecht

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on Acute Myeloid Leukemia (AML) and various forms of Multiple Myeloma, evaluating novel drug combinations and treatment approaches for patients ineligible for intensive chemotherapy.

Blood Cancer Therapies
Leukemia Treatment
Novel Drug Combinations

Studies aim to improve survival rates and treatment outcomes in previously untreated patients.

02 Cardiovascular Medicine

Research centered on atherosclerotic cardiovascular disease and deep vein thrombosis, investigating new therapeutic approaches and preventive strategies.

Heart Disease Management
Blood Clot Prevention
Cardiac Interventions

Clinical trials focus on improving patient outcomes through innovative treatments and prevention strategies.

03 Endocrine Disorders

Studies examining treatments for thyroid conditions and hormonal disorders, comparing conventional and innovative therapeutic approaches.

Thyroid Disease Management
Hormone Therapy
Quality of Life Improvement

Research aims to enhance treatment efficacy while minimizing side effects.

Back to the Netherlands All countries